Paychex (FRA:PCX) Research & Development: €0 Mil (TTM As of Feb. 2026)


FRA:PCX Paychex Inc FRA:PCX
84 GF Score
Price €85.79
GF Value €132.58
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Paychex Research & Development?

Paychex FRA:PCX +3.42% 84 Research & Development is €0 Mil as of Feb. 2026. GuruFocus rates FRA:PCX with a GF Score™ of 84/100 and a GF Value™ of €132.58 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Paychex's Research & Development for the three months ended in Feb. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 was €0 Mil.

Paychex  (FRA:PCX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Paychex Research & Development Related Terms

Paychex Research & Development Historical Data

* Premium members only.

The historical data trend for Paychex's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paychex Research & Development Chart

Paychex Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Paychex Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:PCX
84GF Score
Paychex Inc FRA:PCX
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Paychex Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Paychex (FRA:PCX) has a Research & Development of €0 Mil as of Feb. 2026. Research and development expense is the total cost for research and development activities. View historical data on Paychex and its competitors.
Is Paychex's Research & Development too high?
Paychex's current Research & Development is €0 Mil. Overall, Paychex has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Paychex's Research & Development compare to WDAY and ROP?
Paychex's Research & Development of €0 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Paychex and its competitors. Paychex's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paychex stock overvalued right now?
Based on GuruFocus' analysis, Paychex (FRA:PCX) is currently considered Significantly Undervalued. The stock's GF Value™ is €132.58, compared to a current price of €85.79 — trading 35.3% below its estimated fair value. The current Research & Development is €0 Mil. Paychex's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Paychex (FRA:PCX), the current Research & Development is €0 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Paychex (FRA:PCX) Overvalued in 2026?

Based on GuruFocus' analysis, Paychex stock appears to be undervalued. The current stock price of €85.79 is trading 35.3% below its estimated GF Value™ of €132.58. GuruFocus considers Paychex to be Significantly Undervalued.

Key valuation signals for FRA:PCX:

  • Research & Development: €0 Mil
  • GF Value™: €132.58 vs. price of €85.79 (35.3% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the FRA:PCX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Paychex Business Description

Address 911 Panorama Trail South, Rochester, NY, USA, 14625-2396
Paychex is a cloud-based human capital management provider offering payroll, compliance, talent management, benefits administration, and retirement services. The firm also provides HR outsourcing services, including professional employer organization, or PEO, offerings, enabling clients to reduce HR overhead. Paychex primarily targets small and midsize businesses, although its acquisition of Paycor in 2025 signals the firm's aspirations to expand into the midmarket segment, serving firms with more than 100 employees. As of fiscal 2025, Paychex has approximately 800,000 clients and manages payroll for one in 11 workers in the United States.
84GF Score

Get the complete analysis for FRA:PCX

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€85.79
Price
€132.58
GF Value